Related Experiment Video
Updated: Jan 11, 2026

06:28
Visualization of Low-Level Gamma Radiation Sources Using a Low-Cost, High-Sensitivity, Omnidirectional Compton Camera
Published on: January 30, 2020
13.2K
Seven-probe fiber detector for time-resolved source tracking in HDR-brachytherapy: Pre-clinical experimental
Mathieu Gonod1, Miguel Angel Suarez2, Samir Laskri3
1Medical physics department, Centre Georges François Leclerc (CGFL) - Dijon, Dijon, France.
Medical Physics
|November 8, 2025
Summary
A new Seven-probe Scintillator Detector (7SD) enables precise, real-time in vivo dosimetry (IVD) for high-dose-rate brachytherapy (HDR-BT). This compact, biocompatible system accurately monitors source position and dwell times, enhancing treatment verification and detecting potential errors.
Area of Science:
- Medical Physics
- Radiotherapy Technology
- Biomedical Engineering
Background:
- In vivo dosimetry (IVD) is crucial for verifying high-dose-rate brachytherapy (HDR-BT) delivery.
- Time-resolved techniques like source tracking offer real-time error detection but have been limited in clinical scenarios.
Purpose of the Study:
- Evaluate a compact, biocompatible Seven-probe Scintillator Detector (7SD) for monitoring HDR-BT.
- Assess the 7SD's ability to detect source insertion errors across diverse HDR-BT techniques.
Main Methods:
- Developed a 7SD using Gd2O2S:Tb scintillator probes coupled to optical fibers.
- Tested the 7SD in a phantom with an Ir-192 HDR afterloader, acquiring data at 0.06s intervals.
- Calibrated the probe experimentally and confirmed biocompatibility via cytotoxicity tests.
Main Results:
- Analyzed 4040 dwell positions with high accuracy (99.5% identified).
- Measured dwell positions deviated minimally (0.224 mm radial, 0.077 mm axial) from planned values.
- Detected 99.4% of positions within a 1 mm reliability threshold, identifying systematic afterloader errors.
Conclusions:
- The 7SD is suitable for time-resolved IVD in HDR-BT, enhancing monitoring volume and accuracy.
- The system can detect afterloader malfunctions, improving HDR-BT setup integrity.
- The 7SD's capabilities, biocompatibility, and compatibility suggest strong potential for clinical implementation.

